Novo Nordisk announced on Friday morning that its CEO Lars Fruergaard Jørgensen is stepping down after leading the company for eight years. In a release announcing the decision, the Danish pharma ...

Lars Fruergaard Jørgensen will step down after eight years helming the Danish drugmaker, shares of which have shed half their ...

If you’ve been on TikTok or any other social media — or any kind of media, for that matter — you’ve probably come across ...

Novo Nordisk CEO Lars Jørgensen to step down amid increasing pressure from obesity drug competition and recent share price ...

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...

Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...

A Comprehensive Review of MEDVi’s Personalized GLP-1 Weight Loss Solutions Featuring Affordable Compounded Semaglutide and ...

Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo ...

Weight loss company WeightWatchers has filed for Chapter 11 bankruptcy protection after falling $1.15 billion into debt. The ...

The diet company known as WeightWatchers filed for bankruptcy saying its 62-year-old business model was now under threat amid ...

Global wellness giant Weight Watchers has filed for bankruptcy, while weight-loss drug maker Novo Nordisk cut its full-year forecasts. Read more.